5-MeO-DMT Safety and Tolerability Study
Phase I dose-escalation study assessing pharmacokinetics, safety profile, and subjective effects of synthetic 5-MeO-DMT in healthy volunteers.
- Status
- planned
- Institution
- University of California San Francisco
- Principal investigator
- Dr. Alan Davis
- Start date
- 2025-08-01
- End date
- 2026-12-31
- Registry ID
- NCT05234567
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.